Do All People With Diabetes Get Diabetic Retinopathy?
Diabetes is a condition that affects more than just blood sugar levels—it can have significant impacts on your eyes. One of the most serious eye conditions associated with diabetes is diabetic…
Skip to main menu Skip to main content Skip to footer
" I am passionate about finding better treatments for our patients with sight-threatening eye diseases"
Dr. Clement K. Chan, M.D., FACS is a fellowship-trained retina specialist who has proudly served patients in the Coachella Valley since 1989. Dr. Chan has a long-standing reputation for being a leader in the medical and surgical treatment of retina-related disorders and conditions, such as macular degeneration, diabetic retinopathy, retinal detachment, vein occlusion, macular edema, and more! Dr. Chan serves patients in the Palm Springs, Palm Desert, and Riverside offices.
Dr. Chan obtained his medical degree and ophthalmological training at Loma Linda University, with fellowship training at Washington University in St. Louis, MO. He founded the Desert Retina Consultants (SCDRC) and is the medical director of Inland Retina Consultants (IRC). Today, Dr. Chan is an associate clinical professor at Loma Linda University and is a member of the Retina Society, Macula Society, and Club Jules Gonin — national and international retina honor societies. Dr. Chan was recently named a “Top Doctor 2025” by Palm Springs Life Magazine in recognition of his outstanding contributions to retina care in the Coachella Valley.
In May 2026, Dr. Chan delivered scientific presentations at three national and international retina meetings. At the 162nd Annual Meeting of the American Ophthalmological Society (AOS) in Santa Fe, NM, he presented his research on long-term changes in geographic atrophy, drusen, and macular volume in eyes with intermediate AMD — the PREVENT Trial — and participated in a point-counterpoint podium debate on the benefits and risks of pegcetacoplan for nonexudative AMD. At the XXXV Meeting of Club Jules Gonin in Lugano, Switzerland, he presented landmark five-year outcomes data for pegcetacoplan treatment in geographic atrophy secondary to AMD, one of the longest-duration datasets available for this therapy. He also presented earlier that month at the 12th Combined Annual Meeting of the Pacific Retina Club at UCLA, sharing retrospective claims data on corticosteroid utilization in anti-VEGF-treated diabetic macular edema from 2018 to 2023.
In March 2026, Dr. Chan was appointed to the Editorial Board of RETINA: The Journal of Retinal and Vitreous Diseases, one of the most prestigious peer-reviewed publications in the field. In his own words: “Clinical research and publication remain a core component of our clinical practice, directly benefiting the patients we serve with the latest knowledge and technology. I am grateful to be a part of the editorial board of RETINA, a premier scientific journal in the field of retina, providing the opportunity to further enhance this process.”
Dr. Chan is a passionate and accomplished researcher; he is dedicated to advancing the field of ophthalmology through involvement in clinical trials which focus on finding better treatments for our patients with sight-threatening eye diseases. Dr. Chan and his team of coordinators have been actively involved in research studies since 1995 and are proud to increase the overall standard of vision care for patients through new technologies and therapies. Additionally, Dr. Chan is extremely passionate about teaching through hands-on examples, lectures, and writing in specialty journals. Books are his passion.
Services:
News and Updates:
Serving patients in Palm Desert, Palm Springs and Riverside areas.
